These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 20354121)

  • 1. Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.
    Ramana KV; Tammali R; Srivastava SK
    Mol Cancer Ther; 2010 Apr; 9(4):813-24. PubMed ID: 20354121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle.
    Tammali R; Saxena A; Srivastava SK; Ramana KV
    Endocrinology; 2010 May; 151(5):2140-50. PubMed ID: 20308528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.
    Tammali R; Saxena A; Srivastava SK; Ramana KV
    J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression.
    Saxena A; Shoeb M; Ramana KV; Srivastava SK
    Eur J Cancer; 2013 Oct; 49(15):3311-9. PubMed ID: 23827854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a.
    Saxena A; Tammali R; Ramana KV; Srivastava SK
    Antioxid Redox Signal; 2013 Apr; 18(11):1249-62. PubMed ID: 22978663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells.
    Tammali R; Ramana KV; Singhal SS; Awasthi S; Srivastava SK
    Cancer Res; 2006 Oct; 66(19):9705-13. PubMed ID: 17018629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose reductase regulates platelet-derived growth factor-induced proliferation through mediating cell cycle progression in rat mesangial cells.
    Zou L; Wang W; Xu Z; Zhang N; Jiang T
    Int J Mol Med; 2012 Aug; 30(2):409-16. PubMed ID: 22614447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of aldose reductase prevents colon cancer metastasis.
    Tammali R; Reddy AB; Saxena A; Rychahou PG; Evers BM; Qiu S; Awasthi S; Ramana KV; Srivastava SK
    Carcinogenesis; 2011 Aug; 32(8):1259-67. PubMed ID: 21642355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fargesin Inhibits EGF-Induced Cell Transformation and Colon Cancer Cell Growth by Suppression of CDK2/Cyclin E Signaling Pathway.
    Lee GE; Lee CJ; An HJ; Kang HC; Lee HS; Lee JY; Oh SR; Cho SJ; Kim DJ; Cho YY
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase inhibition prevents allergic airway remodeling through PI3K/AKT/GSK3β pathway in mice.
    Yadav UC; Naura AS; Aguilera-Aguirre L; Boldogh I; Boulares HA; Calhoun WJ; Ramana KV; Srivastava SK
    PLoS One; 2013; 8(2):e57442. PubMed ID: 23460857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO-1/AMPK pathway in colon cancer cells.
    Shukla K; Sonowal H; Saxena A; Ramana KV; Srivastava SK
    Cancer Lett; 2017 Dec; 411():57-63. PubMed ID: 28986187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron-saturated lactoferrin stimulates cell cycle progression through PI3K/Akt pathway.
    Lee SH; Pyo CW; Hahm DH; Kim J; Choi SY
    Mol Cells; 2009 Jul; 28(1):37-42. PubMed ID: 19533041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo.
    Tammali R; Reddy AB; Srivastava SK; Ramana KV
    Angiogenesis; 2011 May; 14(2):209-21. PubMed ID: 21409599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
    Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
    Ong CS; Zhou J; Ong CN; Shen HM
    Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway.
    Le XF; Bedrosian I; Mao W; Murray M; Lu Z; Keyomarsi K; Lee MH; Zhao J; Bast RC
    Cell Cycle; 2006 Aug; 5(15):1654-61. PubMed ID: 16861913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growth.
    Ponnurangam S; Standing D; Rangarajan P; Subramaniam D
    Mol Cancer Ther; 2013 May; 12(5):598-609. PubMed ID: 23427297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells.
    Park JM; Xian XS; Choi MG; Park H; Cho YK; Lee IS; Kim SW; Chung IS
    J Cell Biochem; 2011 Apr; 112(4):1192-205. PubMed ID: 21312237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
    Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
    J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gedunin, A Neem Limonoid in Combination with Epalrestat Inhibits Cancer Hallmarks by Attenuating Aldose Reductase-Driven Oncogenic Signaling in SCC131 Oral Cancer Cells.
    Tanagala KKK; Baba AB; Kowshik J; Reddy GB; Nagini S
    Anticancer Agents Med Chem; 2018; 18(14):2042-2052. PubMed ID: 30062975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.